Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma

Tumors are composed of phenotypically heterogeneous cell populations. The nongenomic mechanisms underlying transitions and interactions between cell populations are largely unknown. Here, we show that diffuse large B-cell lymphomas possess a self-organized infrastructure comprising side population (...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 123; no. 14; pp. 2189 - 2198
Main Authors Koch, Raphael, Demant, Martin, Aung, Thiha, Diering, Nina, Cicholas, Anna, Chapuy, Bjoern, Wenzel, Dirk, Lahmann, Marlen, Güntsch, Annemarie, Kiecke, Christina, Becker, Sabrina, Hupfeld, Timo, Venkataramani, Vivek, Ziepert, Marita, Opitz, Lennart, Klapper, Wolfram, Trümper, Lorenz, Wulf, Gerald G.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 03.04.2014
Subjects
Online AccessGet full text
ISSN0006-4971
1528-0020
1528-0020
DOI10.1182/blood-2013-08-523886

Cover

More Information
Summary:Tumors are composed of phenotypically heterogeneous cell populations. The nongenomic mechanisms underlying transitions and interactions between cell populations are largely unknown. Here, we show that diffuse large B-cell lymphomas possess a self-organized infrastructure comprising side population (SP) and non-SP cells, where transitions between clonogenic states are modulated by exosome-mediated Wnt signaling. DNA methylation modulated SP–non-SP transitions and was correlated with the reciprocal expressions of Wnt signaling pathway agonist Wnt3a in SP cells and the antagonist secreted frizzled-related protein 4 in non-SP cells. Lymphoma SP cells exhibited autonomous clonogenicity and exported Wnt3a via exosomes to neighboring cells, thus modulating population equilibrium in the tumor. •Diffuse large B-cell lymphomas are composed of clonogenic side population (SP) cells and non-SP cells organized in a dynamic equilibrium.•Exosome-mediated Wnt signaling modulates transitions of cell states and tumor progression amenable to drug targeting.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-4971
1528-0020
1528-0020
DOI:10.1182/blood-2013-08-523886